# ZyVersa Therapeutics, Inc. (ZVSA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ZVSA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -1.79M | $ -799.12M | $ 1.20B | $ -14.12M |
| 2025 | $ 0 | $ -25.55M | $ -3.68B | $ 0 | $ -12.39B |
| 2024 | $ 27.4K | $ -9.89M | $ -3.24B | $ 0 | $ 8.52M |
| 2023 | $ 16.9K | $ -106.28M | $ -9.43M | $ 8.7K | $ 11.07M |
| 2022 | $ 0 | $ -15.62M | $ -1.67M | N/A | $ 99.99M |
| 2021 | $ 0 | $ -9.61M | $ -6.03M | $ 0 | $ 73.49M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -84.96 |
| Liabilities / Eq | -1,052.55 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/ZVSA.md)
- [Charts](https://sponda.capital/en/ZVSA/charts.md)
- [Compare](https://sponda.capital/en/ZVSA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.